8-K//Current report
NKGen Biotech, Inc. 8-K
Accession 0001213900-24-104555
CIK 0001845459operating
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 4:10 PM ET
Size
544.6 KB
Accession
0001213900-24-104555
Documents
- 8-Kea0223210-8k_nkgen.htmPrimary
CURRENT REPORT
- EX-10.1ea022321001ex10-1_nkgen.htm
CONDITIONAL INVESTMENT AGREEMENT, DATED NOVEMBER 20, 2024, BY AND BETWEEN NKGEN BIOTECH, INC. AND NKMAX CO., LTD
- EX-99.1ea022321001ex99-1_nkgen.htm
PRESS RELEASE, DATED DECEMBER 2, 2024
- EX-101.SCHnkgn-20241125.xsd
XBRL SCHEMA FILE
- EX-101.DEFnkgn-20241125_def.xml
XBRL DEFINITION FILE
- EX-101.LABnkgn-20241125_lab.xml
XBRL LABEL FILE
- EX-101.PREnkgn-20241125_pre.xml
XBRL PRESENTATION FILE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001213900-24-104555-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLea0223210-8k_nkgen_htm.xml
IDEA: XBRL DOCUMENT
Issuer
NKGen Biotech, Inc.
CIK 0001845459
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001845459
Filing Metadata
- Form type
- 8-K
- Filed
- Dec 1, 7:00 PM ET
- Accepted
- Dec 2, 4:10 PM ET
- Size
- 544.6 KB